Literature DB >> 9596779

Acute and chronic phases of Toxoplasma gondii infection in mice modulate the host immune responses.

T D Nguyen1, G Bigaignon, J Van Broeck, M Vercammen, T N Nguyen, M Delmee, M Turneer, S F Wolf, J P Coutelier.   

Abstract

Murine antibody responses to soluble proteins are generally restricted to the immunoglobulin G1 (IgG1) isotype. When mice were infected with Toxoplasma gondii Beverley and concomitantly immunized with a soluble unrelated protein antigen, a modification in the isotypic distribution of antibodies directed against this nonparasite antigen was observed, with a preferential production of IgG2a. Interestingly, when mice were immunized with a soluble protein antigen during the chronic phase (day 40) of infection with T. gondii Beverley, a similar modification in the isotypic distribution of antiprotein antibodies was observed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9596779      PMCID: PMC108301          DOI: 10.1128/IAI.66.6.2991-2995.1998

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

1.  IL-4-independent regulation of in vivo IL-9 expression.

Authors:  P Monteyne; J C Renauld; J Van Broeck; D W Dunne; F Brombacher; J P Coutelier
Journal:  J Immunol       Date:  1997-09-15       Impact factor: 5.422

2.  Detection of Toxoplasma gondii tachyzoites and bradyzoites in blood, urine, and brains of infected mice.

Authors:  T D Nguyen; M de Kesel; G Bigaignon; P Hoet; G Pazzaglia; M Lammens; M Delmee
Journal:  Clin Diagn Lab Immunol       Date:  1996-11

3.  Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts.

Authors:  R T Gazzinelli; S Hieny; T A Wynn; S Wolf; A Sher
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

4.  Effect of the strain of Toxoplasma gondii on the development of toxoplasmic encephalitis in mice treated with antibody to interferon-gamma.

Authors:  Y Suzuki; K Joh
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

5.  Kinetics of classes and sub-classes of total immunoglobulins and specific antibodies to Schistosoma mansoni during murine infection.

Authors:  D Bout; R Rousseaux; Y Carlier; A Capron
Journal:  Parasitology       Date:  1980-04       Impact factor: 3.234

6.  Protective effect of low doses of an anti-IL-4 monoclonal antibody in a murine model of acute toxoplasmosis.

Authors:  O Villard; E Candolfi; J L Despringre; F Derouin; L Marcellin; S Viville; T Kien
Journal:  Parasite Immunol       Date:  1995-05       Impact factor: 2.280

7.  Effects of IL-12 on helper T cell-dependent immune responses in vivo.

Authors:  A J McKnight; G J Zimmer; I Fogelman; S F Wolf; A K Abbas
Journal:  J Immunol       Date:  1994-03-01       Impact factor: 5.422

8.  Interleukin-12 enhances murine survival against acute toxoplasmosis.

Authors:  I A Khan; T Matsuura; L H Kasper
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

9.  IFN-gamma regulates the isotypes of Ig secreted during in vivo humoral immune responses.

Authors:  F D Finkelman; I M Katona; T R Mosmann; R L Coffman
Journal:  J Immunol       Date:  1988-02-15       Impact factor: 5.422

10.  Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones.

Authors:  D F Fiorentino; M W Bond; T R Mosmann
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

View more
  9 in total

1.  Coinfection with Toxoplasma gondii inhibits antigen-specific Th2 immune responses, tissue inflammation, and parasitism in BALB/c mice infected with Leishmania major.

Authors:  H C Santiago; M A Oliveira; E A Bambirra; A M Faria; L C Afonso; L Q Vieira; R T Gazzinelli
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  Characterization of Toxoplasma gondii SAG2 expressed in insect cells by recombinant baculovirus and evaluation of its diagnostic potential in an enzyme-linked immunosorbent assay.

Authors:  Xiaohong Huang; Xuenan Xuan; Hiroshi Suzuki; Chihiro Sugimoto; Hideyuki Nagasawa; Kozo Fujisaki; Takeshi Mikami; Ikuo Igarashi
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

3.  A Single Locus Controls Interferon Gamma-Independent Antiretroviral Neutralizing Antibody Responses.

Authors:  Melissa Kane; Felicity Deiss; Alexander Chervonsky; Tatyana V Golovkina
Journal:  J Virol       Date:  2018-07-31       Impact factor: 5.103

4.  Toxoplasma gondii infection blocks the development of allergic airway inflammation in BALB/c mice.

Authors:  I Fenoy; M Giovannoni; E Batalla; V Martin; F M Frank; I Piazzon; A Goldman
Journal:  Clin Exp Immunol       Date:  2008-11-20       Impact factor: 4.330

5.  Distinct requirements for IL-6 in polyclonal and specific Ig production induced by microorganisms.

Authors:  D Markine-Goriaynoff; T D Nguyen; G Bigaignon; J Van Snick; J P Coutelier
Journal:  Int Immunol       Date:  2001-09       Impact factor: 4.823

6.  Vaccination against murine toxoplasmosis using recombinant Toxoplasma gondii SAG3 antigen alone or in combination with Quil A.

Authors:  Young-Ha Lee; Dae-Whan Shin; Jae-Ho Lee; Ho-Woo Nam; Myoung-Hee Ahn
Journal:  Yonsei Med J       Date:  2007-06-30       Impact factor: 2.759

7.  Inhibition of Lewis lung carcinoma growth by Toxoplasma gondii through induction of Th1 immune responses and inhibition of angiogenesis.

Authors:  Ju Ock Kim; Sung Soo Jung; Sun Young Kim; Tae Yun Kim; Dae Whan Shin; Jae Ho Lee; Young Ha Lee
Journal:  J Korean Med Sci       Date:  2007-09       Impact factor: 2.153

8.  Immunological interactions between 2 common pathogens, Th1-inducing protozoan Toxoplasma gondii and the Th2-inducing helminth Fasciola hepatica.

Authors:  Catherine M D Miller; Nicholas C Smith; Rowan J Ikin; Nicola R Boulter; John P Dalton; Sheila Donnelly
Journal:  PLoS One       Date:  2009-05-25       Impact factor: 3.240

9.  Characteristics of Infection Immunity Regulated by Toxoplasma gondii to Maintain Chronic Infection in the Brain.

Authors:  Young Sang Hwang; Ji-Hun Shin; Jung-Pyo Yang; Bong-Kwang Jung; Sang Hyung Lee; Eun-Hee Shin
Journal:  Front Immunol       Date:  2018-02-05       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.